According to Genmab's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.45. At the end of 2024 the company had a P/S ratio of 4.32.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.32 | -50.46% |
2023 | 8.72 | -35.86% |
2022 | 13.6 | -31.22% |
2021 | 19.8 | 15.94% |
2020 | 17.1 | -4.97% |
2019 | 18.0 | -14.98% |
2018 | 21.1 | -22.41% |
2017 | 27.2 | -28.12% |
2016 | 37.9 | -20.62% |
2015 | 47.7 | 111.05% |
2014 | 22.6 | 32.01% |
2013 | 17.1 | 109.06% |
2012 | 8.19 | 80.95% |
2011 | 4.53 | -23.31% |
2010 | 5.90 |